Study on the drug and disinfectant resistant genes of Yersina pestis in natural plague foci in Tibet

Expand
  • Qinghai Province Institute for Endemic Disease Control and Prevention, Xining 811602, Qinghai Province, China

Received date: 2017-08-27

  Online published: 2018-02-20

Supported by

Supported by the Natural Science Foundation of Qinghai Province of China (No. 2016-ZJ-789) and Key Laboratory for Plague Prevention and Control of Qinghai Province (No. 2017-ZJ-Y22)

Abstract

Objective To understand whether there is a drug-or disinfectant-resistant strains in natural plague foci in Tibet, and provide the accurate information for clinical treatment of plague. Methods According to the aminoglycoside resistant gene of streptomycin resistant, StrB, StrA, beta lactam antibiotics TEM, SHV, and CTX-M gene, sulfamilamide resistant Sul1, Sul2, and Sul3, and anti-disinfectant QacEdeltal-sul1 gene sequence the National Center for Biotechnology Information (NCBI) released,a pair of primers in each gene was designed separately. DNA of strains isolated from natural plague foci in Tibet were amplified by PCR using every pair of primers. Results Negative and positive control were established, samples by PCR amplification results were negative, there were no streptomycin, sulfamilamide and beta lactam antimicrobial drug resistance genes and anti-disinfectant genes in strains studied. Conclusion The Tibet autonomous region of natural plague foci did not appear to have drug-or disinfectant-resistant Yersina pestis.

Cite this article

HE Jian, YANG Xiao-yan, LI Sheng, JIN Juan, ZHANG Qi, XIN You-quan, JIN Yong, XIONG Hao-ming, YANG Han-qing, WEI Bai-qing, DAI Rui-xia, QI Zhi-zhen . Study on the drug and disinfectant resistant genes of Yersina pestis in natural plague foci in Tibet[J]. Chinese Journal of Vector Biology and Control, 2018 , 29(1) : 61 -63 . DOI: 10.11853/j.issn.1003.8280.2018.01.015

References

[1] Galimand M, Carniel E, Courvalin P. Resistance of Yersinia pestis to antimicrobial agents[J]. Antimicrob Agents Chemother, 2006,50(10):3233-3236.
[2] Carraro N, Matteau D, Luo P, et al. The master activator of incA/C conjugative plasmids stimulates genomic islands and multidrug resistance dissemination[J]. PLoS Genet,2014,10(10):e1004714.
[3] Li YJ, Dai EH, Cui YJ, et al. Different region analysis for genotyping Yersinia pestis isolates from China[J]. PLoS One, 2008,3(5):e2166. DOI:10.1371/journal.pone.0002166.
[4] 赵宏群,占堆,阮水良,等. 西藏自治区2009-2011年鼠疫耶尔森菌分离株的生化特征[J]. 中国媒介生物学及控制杂志, 2017,28(2):175-176,187.
[5] 杨晓艳,辛有全,魏柏青,等. 西藏藏南地区新增疫源县鼠疫菌病原学分析及流行病学意义[J]. 中华地方病学杂志, 2015,34(4):247-249. DOI:10.3760/cma.j.issn.2095-4255. 2015.04.005.
[6] 麻占军,蒋志勇. 西藏自治区1966-2012年人间鼠疫流行病学分析[J]. 中国地方病防治杂志,2013,28(2):119-122.
[7] 西绕若登,李景中,洛桑群增,等. 西藏鼠疫流行现状与青藏铁路沿线鼠疫预防控制对策[J]. 中国地方病防治杂志, 2008,23(3):198-200.
[8] 王国钧,李敏,郑谊,等. 环丙沙星治疗家兔实验感染鼠疫疗效观察[J]. 中国地方病学杂志,2005,24(5):564-565.
[9] 卫生部应急办公室. 鼠疫防控应急手册[M]. 北京:北京大学医学出版社,2009:142.
[10] Galimand M,Guiyoule A,Gerbaud G,et al. Multidrug resistance in Yersinia pestis mediated by a transferable plasmid[J]. N Engl J Med,1997,337(10):677-681.
[11] Guiyoule A, Gerbaud G, Buchrieser C, et al. Transferable plasmid-mediated resistance to streptomycin in a clinical isolate of Yersinia pestis[J]. Emerg Infect Dis,2001,7(1):43-48.
[12] Chanteau S, Ratsitorahina M, Rahalison L, et al. Current epidemiology of human plague in Madagascar[J]. Microbes Infect,2000,2(1):25-31.
[13] Dennis DT, Hughes JM. Multidrug resistance in plague[J]. N Engl J Med,1997,337(10):702-704.
[14] Welch TJ, Fricke WF, McDermott PF, et al. Multiple antimicrobial resistance in plague:an emerging public health risk[J]. PLoS One,2007,2(3):e309. DOI:10.1371/journal.pone.0000309.
[15] Hinnebusch BJ, Rosso ML, Schwan TG, et al. High-frequency conjugative transfer of antibiotic resistance genes to Yersinia pestis in the flea midgut[J]. Mol Microbiol,2002,46(2):349-354.
[16] Wagner DM, Runberg J, Vogler AJ, et al. No Resistance plasmid in Yersinia pestis, North America[J]. Emerg Infect Dis, 2010,16(5):885-887. DOI:10.3201/eid1605.090892.
Outlines

/